PROVECTUS BIOPHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2020 was 7.86M shares, a 55.67% increase from fiscal 2019.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2019 was 5.05M shares, a 60.12% decline from fiscal 2018.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, shares, new issues for fiscal 2018 was 12.65M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2020-12-31 | 7.86M shares 10-K · filed 2021-03-02 | |
| 2019-12-31 | 5.05M shares 10-K · filed 2021-03-02 | |
| 2018-12-31 | 12.65M shares 10-K · filed 2020-03-05 |